Revenue: The sum of all revenue fields included for a company's operating activities.
Syndax Pharmaceuticals, Inc. (SNDX) had Revenue of $20.04M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$20.04M |
$-84.85M |
|
$0.89M |
|
$19.16M |
|
$103.80M |
|
$-83.76M |
|
$-1.09M |
|
$-84.85M |
|
$-84.85M |
|
$-84.85M |
|
$-84.85M |
|
$-84.85M |
|
$-84.85M |
|
$-83.76M |
|
$-87.24M |
|
86.17M |
|
86.17M |
|
$-0.98 |
|
$-0.98 |
|
| Balance Sheet Financials | |
$548.75M |
|
-- |
|
$91.96M |
|
$640.71M |
|
$94.55M |
|
$329.64M |
|
$331.10M |
|
$425.65M |
|
$215.06M |
|
$215.06M |
|
$215.06M |
|
86.05M |
|
| Cash Flow Statement Financials | |
$-95.16M |
|
$94.14M |
|
$0.93M |
|
$154.30M |
|
$154.21M |
|
$-0.09M |
|
$10.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.80 |
|
-- |
|
-- |
|
0.61 |
|
1.60 |
|
95.58% |
|
-417.91% |
|
-417.91% |
|
-- |
|
-423.34% |
|
-423.34% |
|
$-95.16M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
0.19 |
|
1.04 |
|
86.72 |
|
-39.45% |
|
-39.45% |
|
-13.24% |
|
-15.58% |
|
$2.50 |
|
$-1.10 |
|
$-1.10 |
|